Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.99B |
| 2 |
Eli Lilly
LLY
|
+$3.22B |
| 3 |
UnitedHealth
UNH
|
+$2.21B |
| 4 |
Amazon
AMZN
|
+$2.17B |
| 5 |
Applied Materials
AMAT
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$6.48B |
| 2 |
Boeing
BA
|
+$4.34B |
| 3 |
Royal Caribbean
RCL
|
+$2.21B |
| 4 |
Broadcom
AVGO
|
+$1.17B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Consumer Discretionary | 12.86% |
| 3 | Healthcare | 12.73% |
| 4 | Industrials | 10.59% |
| 5 | Financials | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Cabot Corp
CBT
$4.45B
| $35.2M | 0.01% |
462,691
| – | – |
|
377
Cadre Holdings
CDRE
$1.45B
| $34M | 0.01% |
930,318
+217,864
| +31% | +$7.02M |
|
378
Establishment Labs
ESTA
$2.25B
| $33.4M | 0.01% |
814,491
-209,926
| -20% | -$8.58M |
|
379
Autodesk
ADSK
$54.5B
| $32.7M | 0.01% |
103,014
-321,248
| -76% | -$97.9M |
|
380
Tyson Foods
TSN
$19.8B
| $31.4M | 0.01% |
577,683
| – | – |
|
381
IBM
IBM
$223B
| $31M | 0.01% |
+109,935
| New | +$28.8M |
|
382
East-West Bancorp
EWBC
$18.6B
| $30.9M | 0.01% |
290,263
-1,560
| -0.5% | -$164K |
|
383
Vaxcyte
PCVX
$8.76B
| $30.4M | 0.01% |
842,978
-3,928,808
| -82% | -$130M |
|
384
Keurig Dr Pepper
KDP
$42.3B
| $29.7M | 0.01% |
1,164,623
-44
| -0% | -$1.38K |
|
|
CFLT
385
DELISTED
Confluent
CFLT
| $29.2M | 0.01% |
1,475,965
-469,005
| -24% | -$9.81M |
|
386
Stellantis
STLA
$20.2B
| $29M | 0.01% |
3,139,748
-10,561,606
| -77% | -$101M |
|
387
Icon
ICLR
$12.9B
| $28.8M | 0.01% |
164,563
+67,480
| +70% | +$11.3M |
|
388
Analog Devices
ADI
$186B
| $28.7M | 0.01% |
116,826
+953
| +0.8% | +$229K |
|
|
BA.PRA
389
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$8.14B
| $28.3M | 0.01% |
406,339
| – | – |
|
390
Louisiana-Pacific
LPX
$5.18B
| $27.9M | 0.01% |
313,497
| – | – |
|
391
Enliven Therapeutics
ELVN
$4.25B
| $26.9M | 0.01% |
1,315,465
| – | – |
|
392
Vericel Corp
VCEL
$2.28B
| $26.9M | 0.01% |
853,668
| – | – |
|
393
Royal Bank of Canada
RY
$299B
| $26.2M | ﹤0.01% |
177,506
+2,946
| +2% | +$406K |
|
394
Kenvue
KVUE
$36.9B
| $25.6M | ﹤0.01% |
1,578,221
+8,940
| +0.6% | +$182K |
|
395
Savers
SVV
$1.67B
| $25.5M | ﹤0.01% |
+1,926,550
| New | +$22.2M |
|
396
MongoDB
MDB
$38B
| $24.8M | ﹤0.01% |
80,010
-6,160
| -7% | -$1.58M |
|
397
FTI Consulting
FCN
$4.24B
| $23.9M | ﹤0.01% |
+147,614
| New | +$24.5M |
|
398
Energy Fuels
UUUU
$3.64B
| $22.8M | ﹤0.01% |
+1,485,310
| New | +$15.8M |
|
399
Blue Owl Capital
OWL
$19.7B
| $22.4M | ﹤0.01% |
1,320,269
+11,719
| +0.9% | +$223K |
|
400
Denison Mines
DNN
$2.95B
| $22.1M | ﹤0.01% |
8,024,816
-3,431,119
| -30% | -$7.59M |
|
Similar funds
Capital Research Global Investors's Q3 2025 Portfolio in Review
As of Q3 2025, Capital Research Global Investors held 458 positions worth $533B, up 6.7% from $499B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Capital Research Global Investors's Q3 2025 filing shows 30 new, 198 increased, 163 reduced and 25 closed positions. Its largest new stake was Corning: 11,058,929 shares worth $907M. The largest sale was Meta Platforms (Facebook), an estimated $6.48B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Capital Research Global Investors's largest Q3 2025 buy was Corning: 11,058,929 shares worth $907M.
- Capital Research Global Investors added most to NVIDIA in Q3 2025, an estimated $3.99B increase.
- Capital Research Global Investors's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $6.48B.
- Capital Research Global Investors fully exited Ansys in Q3 2025, selling an estimated $984M.
- Capital Research Global Investors's ten largest holdings make up 38% of its $533B portfolio in Q3 2025.
- Capital Research Global Investors opened 30 new positions and closed 25 in Q3 2025.
- Capital Research Global Investors's portfolio value rose 6.7% quarter-over-quarter to $533B.
Based on Capital Research Global Investors's 13F filing for Q3 2025, filed 13 Nov 2025.